Tag: synthetic cannabinoids market size

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#How Will the Calcium Gluconate Market Evolve in Terms of Growth and Size by 2029?#_x000D_

Over the past few years, there has been a swift expansion in the size of the synthetic cannabinoids market. The forecast projects that it will surge from a value of $1.88 billion in 2024 to $2.2 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.1%. Several factors have contributed to this growth historically including escalated demand for substitute drugs, an increase in the population of cannabis consumers, a rise in its use in the pharmaceutical sector, heightened demand for legally accepted highs, and a trending inclination towards self-medication._x000D_

_x000D_

The market size for synthetic cannabinoids is set for swift expansion in the upcoming years. It is projected to reach “$4.19 billion in 2029 with a compound annual growth rate (CAGR) of 17.5%. Factors contributing to growth in the prediction period include the escalating trend for designer drugs, a widespread move towards legalizing cannabis, easy online procurement of synthetic drugs, the soaring trend of vaping, and the increased customization of cannabinoid products. Key trends anticipated in the prediction period incorporate sophisticated techniques in forensic toxicology, the use of machine learning for identifying chemical patterns, cloud-based tracking systems for illicit drugs, breakthroughs in formulating synthetic cannabinoids, and the creation of new cannabinoid analogs._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp_x000D_

_x000D_

#What factors are expected to fuel Calcium Gluconate market growth in the coming years?#_x000D_

As the prevalence of osteoporosis continues to rise, it is anticipated to drive the expansion of the calcium gluconate market. Osteoporosis is a health issue defined by fragile bones as a result of losing bone density and strength. It usually occurs due to inactive lifestyles, insufficient calcium consumption, hormonal shifts, and specific medical conditions or drugs. Calcium gluconate plays a role in managing osteoporosis by complementing dietary calcium and promoting bone health. For example, the Australian Institute of Health and Welfare (AIHW), stated in December 2023, that osteoporosis was responsible for 2,366 deaths, a mortality rate of 6.5 per 100,000 people, accounting for 1.4% of the total deaths in 2022. In 2021-22, there were 9,500 hospital admissions primarily due to osteoporosis, which equals 89 admissions per 100,000 population for those aged 45 and above. Consequently, the upsurge in osteoporosis cases is fostering the development of the calcium gluconate market._x000D_

_x000D_

_x000D_

The synthetic cannabinoids market covered in this report is segmented – _x000D_

_x000D_

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids_x000D_

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals_x000D_

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications_x000D_

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals_x000D_

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids_x000D_

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids_x000D_

_x000D_

#What Notable Trends Are Shaping The Direction Of The Calcium Gluconate Market?#_x000D_

Top corporations in the synthetic cannabinoids market are directing their efforts towards the creation of advanced solutions like fungal expression systems to raise production efficacy and cut down expenses. Genetically engineered fungi are employed in these systems to biosynthesize synthetic cannabinoids, providing a green and expandable substitute to chemical synthesis or plant extraction. These approaches guarantee the production of high-purity cannabinoids for pharmaceutical and research uses. For instance, in January 2022, Dyadic International Inc., a biotechnology firm based in the USA, revealed their C1-cell protein production platform designed to manufacture synthetic cannabinoids. This revolutionary strategy utilizes filamentous fungal cell factories to generate cannabinoids such as cannabidiol (CBD) and its precursors more affordably and sustainably. The procedure is not only environmentally friendly and energy-efficient, but also results in purer regulatory-compliant cannabinoids that could hold therapeutic potential in managing chronic pain, inflammation, and other medical conditions._x000D_

_x000D_

#What Are The Most Active Companies In The Calcium Gluconate Market Today?#_x000D_

Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd. _x000D_

_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report_x000D_

_x000D_

#Which Regional Markets Are Attracting The Most Investment In Calcium Gluconate?#_x000D_

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Synthetic Cannabinoids Market Size from 2025 to 2034?

In recent years, the market size of synthetic cannabinoids has experienced quick growth. Its value is projected to escalate from $1.88 billion in 2024 to $2.2 billion in 2025, with a compound annual growth rate (CAGR) of 17.1%. The past growth is attributed to factors such as the rising demand for alternative drugs, increase in cannabis users, expanding pharmaceutical applications, higher demand for legal highs, and a noticeable shift towards self-medication.

The market for synthetic cannabinoids is anticipated to experience swift expansion in the coming years. The projected growth rate is set to reach a value of $4.19 billion in 2029, with a compound annual growth rate (CAGR) of 17.5%. This growth during the forecast period is largely due to factors such as the increasing popularity of designer drugs, the expanding legalization of cannabis, the rise in online availability of synthetic drugs, the surge in vaping popularity, and the growing trend of personalizing cannabinoid products. Key trends during this period encompass advanced techniques in forensic toxicology, the application of machine learning for recognizing chemical patterns, tracking of illicit drugs via the Cloud, advancements in synthetic cannabinoid composition, and the production of new cannabinoid analogs.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Synthetic Cannabinoids Market?

The synthetic cannabinoids market is anticipated to expand due to the increasing need for neurological disorder treatments. Neurological disorders, which include diseases that affect the brain, spinal cord, and nerves and can impact movement, sensation, cognition, or overall function, are primarily surging due to the aging global population. Disorders like Alzheimer’s are prevalent amongst the elderly because of brain aging and accumulated cellular damage. Synthetic cannabinoids, which target cannabinoid receptors in the brain and manage neurotransmitter activity, could potentially help in alleviating symptoms linked to neurological disorders. For instance, the European Brain Council, a Belgium-based health organization reported in September 2024 that around 7 million people in Europe are living with Alzheimer’s disease. This figure is expected to reach 14 million by 2030 due to an increase in the aging population, positioning it as a crucial worldwide public health issue. Hence, the synthetic cannabinoids market’s growth is backed by the surging demand for neurological disorder treatments.

Which Primary Segments of the Synthetic Cannabinoids Market Are Driving Growth and Industry Transformations?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Synthetic Cannabinoids Market?# Market?

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Synthetic Cannabinoids Market?

Prominent businesses in the synthetic cannabinoids industry are concentrating on the creation of advanced solutions like fungal expression systems, to improve productivity and minimize expenses. Fungal expression systems utilize genetically modified fungi to biosynthesize synthetic cannabinoids, providing a sustainable and scalable substitute to chemical synthesis or plant extraction. Such systems enable the production of high-purity products for pharmaceutical and research purposes. For instance, Dyadic International Inc., an American biotech firm, launched a C1-cell protein production platform specifically for the production of synthetic cannabinoids, in January 2022. This novel method uses filamentous fungal cell factories for the efficient and sustainable production of cannabinoids such as cannabidiol (CBD) and its precursors. The procedure is not only eco-friendly and energy-efficient, but also results in the production of purer, regulatory-compliant cannabinoids, potentially beneficial in treating conditions like chronic pain, inflammation and other medical disorders.

View the full report here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

What Parameters Are Used to Define the Synthetic Cannabinoids Market?

Synthetic cannabinoids are lab-created compounds designed to mimic the effects of natural cannabinoids by binding to cannabinoid receptors in the body. They are produced through advanced chemical synthesis and can be significantly more potent and unpredictable than their natural counterparts. Additionally, some synthetic cannabinoids are used in regulated pharmaceutical applications for therapeutic purposes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23536

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Synthetic Cannabinoids Market Growth in 2025?

The market size of synthetic cannabinoids has experienced a significant expansion in the past few years. From being valued at $1.88 billion in 2024, it is projected to increase to $2.22 billion in 2025, representing a compound annual growth rate (CAGR) of 18.3%. The unprecedented growth observed in the historical period is due to factors such as rising demands for substitute drugs, an increased user base for cannabis, growing utilisation in pharmaceutical applications, increasing demand for legal highs, and a notable shift towards self-medication.

What Is the Forecast for the Synthetic Cannabinoids Market Size Through 2029?

In the forthcoming years, the synthetic cannabinoids market is poised for swift expansion, anticipated to reach $4.30 billion by 2029, witnessing a compound annual growth rate (CAGR) of 17.9%. Factors contributing to this rise during the prognosis period include the soaring demand for designer drugs, an increasing trend for legalization of cannabis, enhanced online availability of synthetic drugs, the expanding popularity of vaping, and an upswing in the customization of cannabinoid products. Notable trends for the forecast duration encompass progressed forensic toxicology tactics, employing machine learning for recognizing chemical patterns, tracking of illicit drugs via cloud-based systems, breakthroughs in synthetic cannabinoid concoctions, and the generation of innovative cannabinoid analogs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What are the Key Market Players in Synthetic Cannabinoids Market and How They’re Evolving?

Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd.

What Are the Primary Growth Drivers in the Synthetic Cannabinoids Market?

The synthetic cannabinoids market is predicted to grow, fueled by the increasing need for treatments for neurological disorders. Neurological disorders, which hinder movement, sensation, cognition, or general functioning, are conditions affecting the brain, spinal cord, and nerves. These disorders are becoming more prevalent, largely due to an aging world population and diseases like Alzheimer’s becoming more frequent with age because of brain aging and accumulated cell damage. Synthetic cannabinoids have the potential to offer relief from these disorders’ symptoms as they target cannabinoid receptors in the brain and play a role in regulating neurotransmitter activity. For example, the Belgium-based European Brain Council reported in September 2024 that 7 million people in Europe are currently living with Alzheimer’s disease. This number is predicted to double by 2030 to 14 million due to aging, creating a significant global public health issue. Therefore, the growing need for neurological disorder treatments fuels the expansion of the synthetic cannabinoids market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

What Are the Leading Segments in the Global Synthetic Cannabinoids Industry?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

What Are the Key Market Trends in the Synthetic Cannabinoids Industry?

The synthetic cannabinoids market is being shaped by major companies that are focusing on the development of advanced solutions such as fungal expression systems. By genetically engineering fungi to biologically produce synthetic cannabinoids, businesses can boost production efficacy and lower costs in a scalable and sustainable manner. An alternative to plant extraction or chemical synthesis, this method is suitable for high-purity production for research and pharmaceutical purposes. For instance, Dyadic International Inc., a US biotech firm, introduced C1-cell protein production platform in January 2022 for the production of synthetic cannabinoids. This unique approach employs filamentous fungal cell factories to produce cannabinoids like cannabidiol (CBD) and its precursors in a more cost-effective and sustainable way. Additionally, it is an environmentally friendly and energy-efficient process capable of creating purer cannabinoids in compliance with regulations, potentially useful in treating areas such as inflammation, chronic pain, and other health conditions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

What Is the Regional Outlook for the Synthetic Cannabinoids Market?

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23536

This Report Delivers Insight On:

1. How big is the synthetic cannabinoids market, and how is it changing globally?

2. Who are the major companies in the synthetic cannabinoids market, and how are they performing?

3. What are the key opportunities and risks in the synthetic cannabinoids market right now?

4. Which products or customer segments are growing the most in the synthetic cannabinoids market?

5. What factors are helping or slowing down the growth of the synthetic cannabinoids market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Synthetic Cannabinoids Market Growth in 2025?

The market size of synthetic cannabinoids has experienced a significant expansion in the past few years. From being valued at $1.88 billion in 2024, it is projected to increase to $2.22 billion in 2025, representing a compound annual growth rate (CAGR) of 18.3%. The unprecedented growth observed in the historical period is due to factors such as rising demands for substitute drugs, an increased user base for cannabis, growing utilisation in pharmaceutical applications, increasing demand for legal highs, and a notable shift towards self-medication.

What Is the Forecast for the Synthetic Cannabinoids Market Size Through 2029?

In the forthcoming years, the synthetic cannabinoids market is poised for swift expansion, anticipated to reach $4.30 billion by 2029, witnessing a compound annual growth rate (CAGR) of 17.9%. Factors contributing to this rise during the prognosis period include the soaring demand for designer drugs, an increasing trend for legalization of cannabis, enhanced online availability of synthetic drugs, the expanding popularity of vaping, and an upswing in the customization of cannabinoid products. Notable trends for the forecast duration encompass progressed forensic toxicology tactics, employing machine learning for recognizing chemical patterns, tracking of illicit drugs via cloud-based systems, breakthroughs in synthetic cannabinoid concoctions, and the generation of innovative cannabinoid analogs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What are the Key Market Players in Synthetic Cannabinoids Market and How They’re Evolving?

Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd.

What Are the Primary Growth Drivers in the Synthetic Cannabinoids Market?

The synthetic cannabinoids market is predicted to grow, fueled by the increasing need for treatments for neurological disorders. Neurological disorders, which hinder movement, sensation, cognition, or general functioning, are conditions affecting the brain, spinal cord, and nerves. These disorders are becoming more prevalent, largely due to an aging world population and diseases like Alzheimer’s becoming more frequent with age because of brain aging and accumulated cell damage. Synthetic cannabinoids have the potential to offer relief from these disorders’ symptoms as they target cannabinoid receptors in the brain and play a role in regulating neurotransmitter activity. For example, the Belgium-based European Brain Council reported in September 2024 that 7 million people in Europe are currently living with Alzheimer’s disease. This number is predicted to double by 2030 to 14 million due to aging, creating a significant global public health issue. Therefore, the growing need for neurological disorder treatments fuels the expansion of the synthetic cannabinoids market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

What Are the Leading Segments in the Global Synthetic Cannabinoids Industry?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

What Are the Key Market Trends in the Synthetic Cannabinoids Industry?

The synthetic cannabinoids market is being shaped by major companies that are focusing on the development of advanced solutions such as fungal expression systems. By genetically engineering fungi to biologically produce synthetic cannabinoids, businesses can boost production efficacy and lower costs in a scalable and sustainable manner. An alternative to plant extraction or chemical synthesis, this method is suitable for high-purity production for research and pharmaceutical purposes. For instance, Dyadic International Inc., a US biotech firm, introduced C1-cell protein production platform in January 2022 for the production of synthetic cannabinoids. This unique approach employs filamentous fungal cell factories to produce cannabinoids like cannabidiol (CBD) and its precursors in a more cost-effective and sustainable way. Additionally, it is an environmentally friendly and energy-efficient process capable of creating purer cannabinoids in compliance with regulations, potentially useful in treating areas such as inflammation, chronic pain, and other health conditions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

What Is the Regional Outlook for the Synthetic Cannabinoids Market?

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23536

This Report Delivers Insight On:

1. How big is the synthetic cannabinoids market, and how is it changing globally?

2. Who are the major companies in the synthetic cannabinoids market, and how are they performing?

3. What are the key opportunities and risks in the synthetic cannabinoids market right now?

4. Which products or customer segments are growing the most in the synthetic cannabinoids market?

5. What factors are helping or slowing down the growth of the synthetic cannabinoids market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Get 30% off on our Global Market Reports with code ONLINE30 – Hurry, limited time offer!

What Are the Key Milestones in the Synthetic Cannabinoids Market’s Growth Trajectory From 2025 To 2034?

The market size of synthetic cannabinoids has experienced a swift expansion in the past few years. The market, which was valued at $1.88 billion in 2024, is expected to rise to $2.22 billion in 2025, representing a compound annual growth rate of 18.3%. The surge in historical period growth can be credited to escalating demands for substitute drugs, an increase in the number of cannabis consumers, the rise in pharmaceutical uses, burgeoning demand for legal highs, and a notable trend of self-medication.

The market size of synthetic cannabinoids is predicted to witness speedy expansion in the approaching years. The market is set to surge to $4.30 billion by 2029, with a compound annual growth rate (CAGR) of 17.9%. This anticipated growth during the forecast period is due to a variety of factors, including the growing favorability of designer drugs, the increasing legalization of cannabis, the amplified online availability of synthetic drugs, the soaring popularity of vaping, and the progressive customization of cannabinoid items. The forecast period also presents significant trends such as improvement in forensic toxicology methods, utilization of machine learning for identifying chemical patterns, cloud-based tracking of unlawful drugs, advancements in the formulation of synthetic cannabinoids, and the creation of innovative cannabinoid analogs.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Synthetic Cannabinoids Market?

The synthetic cannabinoids market’s expansion is thought to be fueled by the escalating need for treatments for neurological disorders. Diseases of the brain, spinal cord, and nerves that impair movement, sensation, cognition, or overall operation are neurological disorders. The rise in these disorders is mainly attributable to the aging global population since disorders like Alzheimer’s become more prevalent with age due to the aging of the brain and accumulated cellular damage. Synthetic cannabinoids influence cannabinoid receptors in the brain, helping to manage neurotransmitter activity and possibly mitigate symptoms linked to neurological disorders. For example, the European Brain Council, a Belgium-based health entity, reported in September 2024 that currently, 7 million people in Europe are living with Alzheimer’s disease. This number is projected to double to 14 million by 2030 due to an aging population, posing a substantial global public health concern. Hence, the escalating need for treatments for neurological disorders is propelling the synthetic cannabinoids market’s expansion.

Which Key Market Segments Comprise the Synthetic Cannabinoids Market and Drive Its Revenue Growth?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

Which Areas Are Leading Regions in the Synthetic Cannabinoids Market Expansion Across the Globe?

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive the Synthetic Cannabinoids Market’s Growth?

Leading firms in the synthetic cannabinoids market are concentrating their efforts on the creation of innovative solutions, including the use of fungal expression systems, to improve production effectiveness and decrease expenses. Utilizing genetically modified fungi to biosynthesize synthetic cannabinoids is a key feature of fungal expression systems, offering a sustainable and scalable substitute for chemical synthesis or plant extraction. This method guarantees high-purity production suitable for pharmaceutical and research purposes. For example, Dyadic International Inc., a biotech company from the US, introduced a C1-cell protein production system for the production of synthetic cannabinoids in January 2022. This ground-breaking approach employs filamentous fungal cell factories to more economically and sustainably produce cannabinoids such as cannabidiol (CBD) and its precursors. The method is eco-friendly, energy efficient, and capable of creating higher-quality, regulation-compliant cannabinoids that may have medicinal uses in areas like chronic pain, inflammation, and other health ailments.

View the full report here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

How Is the Synthetic Cannabinoids Market Conceptually Defined?

Synthetic cannabinoids are lab-created compounds designed to mimic the effects of natural cannabinoids by binding to cannabinoid receptors in the body. They are produced through advanced chemical synthesis and can be significantly more potent and unpredictable than their natural counterparts. Additionally, some synthetic cannabinoids are used in regulated pharmaceutical applications for therapeutic purposes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23536

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model